Analysts HC Wainwright, BTIG Research, and Royal Bank of Canada reaffirm/raise "Buy" ratings and target prices for Verastem and Vera Therapeutics. Los analistas HC Wainwright, BTIG Research y Royal Bank of Canada reafirman/aumentan las calificaciones de "Compra" y los precios objetivo de Verastem y Vera Therapeutics.